REMOZEN V TABLET contains Remogliflozin and Vildagliptin which belongs to the group of medicines called Anti-diabetic agents. REMOZEN V TABLET is used to manage type 2 diabetes when diet and exercise alone are insufficient to provide adequate glycaemic control in adult patients.

Along management with REMOZEN V TABLET, your doctor might advise you to follow the diet and/or exercise which is beneficial. Avoid consumption of alcohol while taking REMOZEN V TABLET because it might lead to low blood glucose levels.

REMOZEN V TABLET is not recommended for use in patients allergic to Remogliflozin and Vildagliptin. It is also not recommended for use in patients with liver problems and/or kidney problems. Before taking [GBKEYWORD], inform your doctor if you have type 1 diabetes, dehydration (associated with symptoms such as nausea, vomiting, and/or loss of excessive fluid from the body), and/or low blood pressure.

REMOZEN V TABLET is not recommended for use during pregnancy and in women planning for pregnancy. It is also not recommended for use in breastfeeding women since it is not known whether the medicine may pass through breast milk. The most common side effects of taking [GBKEYWORD] are constipation, diarrhoea, weakness, dizziness, fever, joint pain, chills, urinary tract infection, and headache. Consult your doctor if any of these above side effects worsens or persists for a longer duration.